Results 281 to 290 of about 68,882 (316)
Some of the next articles are maybe not open access.
New England Journal of Medicine, 2002
The thrombotic microangiopathies (TMA) are a group of diseases associated with microangiopathic hemolytic anemia, thrombocytopenia, and end-organ dysfunction. These seemingly disparate entities share in common a pathogenic mechanism involving endothelial injury and thrombus formation.
Daniel, Halevy +3 more
+9 more sources
The thrombotic microangiopathies (TMA) are a group of diseases associated with microangiopathic hemolytic anemia, thrombocytopenia, and end-organ dysfunction. These seemingly disparate entities share in common a pathogenic mechanism involving endothelial injury and thrombus formation.
Daniel, Halevy +3 more
+9 more sources
Modern Rheumatology Case Reports, 2022
Thrombotic microangiopathy is characterised by endothelial cell injury, intravascular platelet-fibrin thrombi, and vascular damage, leading to acute kidney injury, thrombocytopenia, and microangiopathic haemolytic anaemia.
Fumiya Kitamura +11 more
semanticscholar +1 more source
Thrombotic microangiopathy is characterised by endothelial cell injury, intravascular platelet-fibrin thrombi, and vascular damage, leading to acute kidney injury, thrombocytopenia, and microangiopathic haemolytic anaemia.
Fumiya Kitamura +11 more
semanticscholar +1 more source
A case of thrombotic microangiopathy/microangiopathies
Blood Coagulation & Fibrinolysis, 2014We report a case of Streptococcus pneumonia sepsis-associated disseminated intravascular coagulation (DIC) with features of acute renal failure and microvascular thrombosis characterized by skin purpura and bilateral foot necrosis. The persistence of laboratory features of microangiopathic hemolytic anemia despite aggressive correction of DIC ...
Rohit Kumar +2 more
openaire +3 more sources
Severe COVID‐19 infection and thrombotic microangiopathy: success does not come easily
British Journal of Haematology, 2020Recent evidence suggests that signs and symptoms of severe COVID-19 infection resemble more the pathophysiology and phenotype of complement-mediated thrombotic micoangiopathies (TMA), rather than sepsis-induced coagulopathy or disseminated intravascular ...
E. Gavriilaki, R. Brodsky
semanticscholar +1 more source
Relationship between periodontitis and microangiopathy in type 2 diabetes mellitus: a meta-analysis.
Journal of Periodontal Research, 2021OBJECTIVE Whether periodontitis increases the risk of diabetic microangiopathy remains controversial. The present meta-analysis aims to investigate the relationship between periodontitis and diabetic microangiopathy in patients with type 2 diabetes ...
Xuexue Zhang +9 more
semanticscholar +1 more source
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2022
The review article highlights the main points of the development of cerebral microangiopathy - «small vessel diseases». Cerebral microangiopathy or small vessel disease. Cerebral microangiopathy is one of the leading causes of the development of acute and/or chronic cerebral circulatory disorders and cognitive disorders up to severe dementia.
A.S. Chukanova +3 more
openaire +2 more sources
The review article highlights the main points of the development of cerebral microangiopathy - «small vessel diseases». Cerebral microangiopathy or small vessel disease. Cerebral microangiopathy is one of the leading causes of the development of acute and/or chronic cerebral circulatory disorders and cognitive disorders up to severe dementia.
A.S. Chukanova +3 more
openaire +2 more sources
Acta Paediatrica, 1998
Microvascular complications of diabetes include retinopathy, nephropathy and neuropathy. The first signs of these complications may develop in children and adolescents, particularly if insulin treatment has been inadequate. The mechanisms by which diabetic microangiopathy develop are not known, but probably include genetic influences.
openaire +2 more sources
Microvascular complications of diabetes include retinopathy, nephropathy and neuropathy. The first signs of these complications may develop in children and adolescents, particularly if insulin treatment has been inadequate. The mechanisms by which diabetic microangiopathy develop are not known, but probably include genetic influences.
openaire +2 more sources
Seminars in Arthritis and Rheumatism, 2014
To review the clinical features and pathophysiologic mechanisms of the thrombotic microangiopathies (TMAs) including acquired and congenital thrombotic thrombocytopenic purpura (TTP), Shiga toxin-induced and atypical (non-Shiga toxin-induced) hemolytic uremic syndrome (HUS), and the TMAs associated with pregnancy, drugs, and organ transplantation ...
openaire +4 more sources
To review the clinical features and pathophysiologic mechanisms of the thrombotic microangiopathies (TMAs) including acquired and congenital thrombotic thrombocytopenic purpura (TTP), Shiga toxin-induced and atypical (non-Shiga toxin-induced) hemolytic uremic syndrome (HUS), and the TMAs associated with pregnancy, drugs, and organ transplantation ...
openaire +4 more sources
Transfusion and Apheresis Science, 2011
Thrombotic microangiopathy (TMA) is a histopathological feature of various diseases including thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). There are many secondary causes of TMA, many of them could mimic TTP or HUS. This article presents a short overview on TMA.
M, Mörtzell +18 more
openaire +2 more sources
Thrombotic microangiopathy (TMA) is a histopathological feature of various diseases including thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). There are many secondary causes of TMA, many of them could mimic TTP or HUS. This article presents a short overview on TMA.
M, Mörtzell +18 more
openaire +2 more sources
Ugeskrift for laeger, 2009
The thrombotic microangiopathic diseases, which include acquired and congenital TTP and HUS, are most frequently acute disease entities. Untreated, these diseases are associated with a lethal course in many cases. Deficiency of the von Willebrand cleaving enzyme, ADAMTS13, is a decisive pathophysiological defect in most cases of thrombotic ...
Cynthia C. Nast, Sharon G. Adler
openaire +4 more sources
The thrombotic microangiopathic diseases, which include acquired and congenital TTP and HUS, are most frequently acute disease entities. Untreated, these diseases are associated with a lethal course in many cases. Deficiency of the von Willebrand cleaving enzyme, ADAMTS13, is a decisive pathophysiological defect in most cases of thrombotic ...
Cynthia C. Nast, Sharon G. Adler
openaire +4 more sources